How to Buy Sarepta Therapeutics Stock
Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to the discovery and advancement of genetic treatment modalities, including RNA-targeted therapeutics and gene therapies, specifically for rare diseases.
Sarepta Therapeutics stock last closed at $17.53, up 3.36% from the previous day, and has decreased 15.6% in one year. It has overperformed other stocks in the Biotechnology industry by 0.56 percentage points. Sarepta Therapeutics stock is currently +68.31% from its 52-week low of $10.42, and -30.77% from its 52-week high of $25.32.
As of Jun 18, 2026, there are 105.58M shares of SRPT outstanding. The market value of SRPT is $1.85B. In the last 24 hours, 5.61M SRPT shares were traded.
How to Buy Sarepta Therapeutics Stock
Wondering how to invest in Sarepta Therapeutics stock? Here's how.
- Decide where to buy Sarepta Therapeutics stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Sarepta Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your method of payment and add your info.
- Analyze Sarepta Therapeutics stock: The Sarepta Therapeutics ticker symbol is SRPT. Is Sarepta Therapeutics stock a good investment? Should you buy shares of SRPT? How do SRPT's underlying business fundamentals look? Do top analysts think Sarepta Therapeutics is a good buy? Why has SRPT's stock price moved recently? (Hint: Our stock market research tools can help you understand if SRPT is a good stock to buy).
- Make your SRPT trade: Decide if you will purchase SRPT shares at the current market price or use a limit order to purchase SRPT shares at a particular price.
- Keep tabs on your SRPT investment: Create a watchlist to get live updates on your investment in Sarepta Therapeutics stock.
Step 1: Decide where to buy Sarepta Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy SRPT stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the right brokerage, you'll need to fill out some personal information so you can invest in SRPT stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create your new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've filled out your info on the best stock trading app, you need to deposit funds:
Check out the video below to see the process of transferring funds into your investment account.
Step 4: Analyze Sarepta Therapeutics stock
After you have figured out the best place to buy Sarepta Therapeutics stock, it's very important to research their stock before you buy, so you truly understand the risk as well as the opportunity.
Sarepta Therapeutics quick stats
Fundamentals of Sarepta Therapeutics
WallStreetZen was built to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on SRPT's stock page.
Is SRPT stock properly valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge SRPT's intrinsic value.
Using relative valuations methods:
- SRPT may be overvalued based on its P/E ratio of 29.22x, relative to Biotechnology industry P/E ratio of 15.77x
- SRPT could be undervalued based on its P/B ratio of 1.23x, relative to Biotechnology industry P/B ratio of 4.95x
- SRPT could be overvalued based on its PEG ratio of 13.22x
You can access more valuation research on SRPT's stock here.
SRPT Financials at a glance
Passed Financial Due Diligence Checks:
- SRPT earnings of $24.47M is not enough to cover its interest payments.
- There are more short-term assets than long-term liabilities on the SRPT balance sheet.
- Total SRPT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the SRPT balance sheet.
- SRPT profit margin has gone up from -11.1% to 3% in the past year.
Failed Financial Due Diligence Checks:
- SRPT's operating cash flow of $175.28M allows it to safely service it's debt of $1.04B.
- SRPT has a relatively high debt to equity ratio of 1.11.
Is SRPT stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 6 Equities analysts who monitor SRPT, the consensus analyst rating on SRPT is a Hold
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest SRPT Analyst Forecasts
Yun Zhong, a bottom 4% analyst from Wedbush maintains SRPT with a buy rating and raises their SRPT price target from $32.00 to $34.00, on Jan 23, 2026.
You can dive deeper into what analysts are projecting on the Sarepta Therapeutics stock forecast page.
Metrics for Advanced SRPT Traders
SRPT Performance Numbers
Last year, SRPT earnings were $65.06M. Over the last 2 year, SRPT's earnings have gone up by 20.97% per year. This was faster than the Biotechnology industry average of 12.57%.
Last year, SRPT revenue was $2.18B. During the last five year, SRPT's revenue has grown by 30.67% per year. This was slower than the Biotechnology industry average of 32.37%.
Dive into SRPT's earnings and revenue performance here.
What are SRPT insiders up to?
In the past year, executives and large shareholders at SRPT have sold more shares than they have bought.
Stephen Mayo, Director of SRPT, was the latest SRPT insider to sell. They sold $123,207.78 worth of SRPT stock on Mar 12, 2026.
Get more info about who owns SRPT stock here.
Can I get consistent income from SRPT stock?
No, Sarepta Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about SRPT?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your SRPT trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually sufficient. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact price, use a limit order.
Click the Open Trade button and your broker will execute the order.
If you require more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your SRPT investment
Now that you own some SRPT stock, you'll want to keep up with your new shares.
Create a watchlist to keep tabs on your SRPT stock.
SRPT Feed
How to Buy Stock in Sarepta Therapeutics
To reiterate, here are the 6 steps to buy stock in Sarepta Therapeutics:
- Decide where to buy Sarepta Therapeutics stock
- Open a brokerage account
- Deposit funds into your investment account
- Analyze Sarepta Therapeutics stock
- Make your SRPT trade
- Keep tabs on your SRPT investment
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Sarepta Therapeutics, add SRPT to your watchlist by clicking the button below.
Other "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.